A phase 1 study of EPZ-6438 (E7438), an Enhancer of Zeste-Homolog 2 (EZH2) inhibitor: Preliminary activity in INI1-negative tumors

Date 26 September 2015
Event European Cancer Congress 2015
Session Early Drug Development I
Topics Drug Development
Presenter Italiano, A.